Prevalence and factors associated with medication adherence in children with central precocious puberty: a

Chunsong Yang1,2,3,4, Xia Song1,2,3,4,5, Jin Wu6

  • 1Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China.

Frontiers in Pharmacology
|January 23, 2024
PubMed

Insights

Medication adherence in children with central precocious puberty (CPP) is generally good, but caregiver factors like understanding medication harm and cost influence adherence. Enhancing caregiver education is key to improving treatment outcomes.

Area of Science:

  • Pediatric Endocrinology
  • Pharmacology
  • Public Health

Background:

  • Central precocious puberty (CPP) requires long-term medication adherence for effective treatment.
  • Factors influencing medication adherence in pediatric CPP patients are not fully understood.
  • Optimizing adherence is crucial for achieving desired therapeutic outcomes and preventing complications.

Purpose of the Study:

  • To determine the prevalence of medication adherence in children with CPP.
  • To identify factors associated with medication adherence in this pediatric population.
  • To inform clinical strategies for improving adherence in CPP management.

Main Methods:

  • A cross-sectional study was conducted with 125 children with CPP and their caregivers.
  • Data collected via questionnaires included patient/caregiver characteristics, medication details, and adherence using the MMAS-8 scale.
  • Univariate and multivariate analyses were performed to identify influencing factors.

Main Results:

  • The overall medication adherence rate in children with CPP was 76.0%.
  • Poor adherence was associated with caregiver factors such as education level, financial burden, and medication cognition.
  • Independent risk factors for poor adherence included adverse effects, lack of understanding non-compliance harm, and perceived high medication cost.

Conclusions:

  • Medication adherence in pediatric CPP is relatively high, with caregiver-related factors playing a significant role in non-adherence.
  • Targeted health education for caregivers is recommended to improve understanding of CPP and its treatment.
  • Enhancing caregiver cognition can lead to better medication adherence and improved therapeutic efficacy.

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
68
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
356
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
45
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.5K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
148